Answer
Nov 07, 2024 - 01:53 PM
Cafergot, a medication used to treat migraines, was taken off the market in some regions due to concerns about safety and the availability of newer, more effective treatments. Specifically, the ergotamine component in Cafergot can cause serious side effects, such as ergotism and cardiovascular issues, especially when not used according to guidelines. Additionally, the market withdrawal may also be related to regulatory decisions or manufacturing issues rather than a global discontinuation.
